Navigen Overview

  • Founded
  • 2014
  • Status
  • Private
  • Employees
  • 21
  • Latest Deal Type
  • Seed
  • Latest Deal Amount
  • $1.5M
Latest Deal Amount
  • Investors
  • 3

Navigen General Information


Operator of a biotechnology company intended focus on drug discovery and development. The company's services involve developing therapeutics for the treatment of hemorrhagic fevers, acute respiratory distress syndrome, pulmonary fibrosis, retinopathies, arthritis, cancer and thrombosis, enabling healthcare providers to access live saving drugs for therapies.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Primary Office
  • 675 Arapeen Drive
  • Suite 103
  • Salt Lake City, UT 84108
  • United States
+1 (385) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Navigen Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Seed Round 04-Oct-2018 $1.5M 00.00 Completed Startup
1. Grant 0000 Completed Startup

Navigen Executive Team (4)

Name Title Board Seat Contact Info
Brandi Simpson President, Chief Executive Officer & Board Member
Alan Wahl Acting Chief Scientific Officer
Hunter Jackson Ph.D Executive Chairman & Co-Founder

1 Former Executive

Navigen Board Members (10)

To view Navigen‘s full board member team, request access »
Name Representing Role Since
Brandi Simpson Navigen President, Chief Executive Officer & Board Member 000 0000
David Clark Navigen Board Member 000 0000
Frank Karbe Navigen Board Member 000 0000
Hunter Jackson Ph.D Navigen Executive Chairman & Co-Founder 000 0000
Jeffrey Fink Navigen Board Member 000 0000

1 Former Board Member

Navigen Investors (3)

To view Navigen‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
University Venture Fund Impact Investing Minority 000 0000 000000 0
National Institutes of Health Government 000 0000 000000 0
United States Department of Defense Government 000 0000 000000 0

Ready to get started?

Request a free trial